influence gene expression during cell differentiation 6 . However, how environmental factors affect cell differentiation through gene expression regulation is unclear.
The pollutant butyl benzyl phthalate (BBP) is ubiquitously present in the environment. BBP is widely used as a plasticizer in the polyvinyl chloride industry and is commonly found in a variety of products such as automotive trim, food packaging, medical products and children's toys 7 . BBP is an external plasticizer, i.e., used in resin softening without chemical binding to the final product. Therefore, BBP tends to migrate slowly out of discarded plastics and disperse into aqueous environments 8, 9 ; hence, BBP may enter the food chain 10 . In addition, phthalates have been classified as endocrine-disrupting chemicals (EDCs) and may interfere with the endocrine system to produce adverse developmental, reproductive, neurological, and immunological effects [11] [12] [13] . In previously study, Upson K et al. finding that urinary concentration of the BBP metabolite MBzP (mono-n-benzyl phthalate) may be associated with increased risk of endometriosis 14 . Reddy et al. has demonstrated the relationship between exposure to polyethylenes such as BBP and the occurrence of endometriosis in infertile women 15 . MicroRNAs (miRNAs) are small, endogenous non-coding RNAs that regulate gene expression by forming imperfect base pairing to sequences in the 3′ untranslated regions (UTRs) of their target mRNAs, thereby triggering translational repression. miRNAs influence a variety of biological processes including development, tissue morphogenesis, cell growth, and maintenance of tissue identity 16 . Emerging evidence indicates that miRNAs have a critical role in the self-renewal and differentiation of MSCs 17 . In addition to the contribution of genetic background, increasing evidence indicates that EDCs may affect MSC differentiation 18, 19 . Therefore, the aim of the present study was to evaluate the effect of BBP on the differentiation of EN-MSCs and to investigate the relationship between BBP and epigenetic-modulated gene expression.
Results

EN-MSCs differentiate into adipogenic, osteogenic, chondrogenic, and myogenic lineages.
To investigate the differentiation potential of EN-MSCs, we cultured cells from endometrium under conditions that favored adipogenic, osteogenic, chondrogenic, or myogenic differentiation. Cytochemical and immunofluorescence staining and quantitative real-time PCR (qPCR) were performed to determine the capacity for EN-MSCs to undergo various lineage differentiations after induction. Adipogenic, osteogenic, or chondrogenic differentiation of EN-MSCs was identified by Oil Red O, Alizarin Red S, or Alcian Blue staining of the respective markers ( Supplementary Fig. S1A and B) . Subsequent qPCR analysis revealed increased expression of the respective adipogenic-, osteogenic-, and chondrogenic-specific markers FABP4, Runx2, and collagen II ( Supplementary Fig. S1C ).
Myogenic differentiation, as assayed by immunoreactivity for MyoD (last two panels; Supplementary Fig. S1A ) and qPCR analysis of transcript levels of myogenic markers, was also increased (last one panel; Supplementary  Fig. S1B ). These data suggested that the endometrium contains cells that have MSC properties associated with multiple lineage differentiation.
BBP decreases EN-MSC adipogenic and myogenic differentiation.
To assess how BBP influences EN-MSC differentiation, cells were treated with 1 μM BBP during the induction period corresponding to multiple lineage differentiation. After EN-MSC differentiation induction and/or BBP treatment, adipogenic, osteogenic, chondrogenic, and myogenic differentiation was analyzed by cytochemical and immunofluorescence staining. In the absence of BBP treatment, EN-MSC differentiation after induction into the four lineages of interest was not affected; in contrast, in the presence of the BBP, EN-MSC differentiation was affected ( Fig. 1A and Supplementary  Fig. S2A and B) . Further, we assessed whether BBP could influence the expression of marker genes during differentiation. BBP decreased the expression of the adipogenic marker FABP4, PPARγ2 and myogenic marker MyoD, Myf5 in each of the non-differentiated and differentiated condition ( Fig. 1B and Supplementary Fig. S2C ). These data revealed that BBP affected EN-MSC differentiation. We next examined the phenotype of BBP affected the myogenic differentiation of EN-MSC, we performed the RNA extraction and PCR to detect the level of endometrial MSC markers sushi Domain Containing 2 (SUSD2). The data showed that the level of SUSD2 markers was decreases in BBP treated EN-MSC, suggesting BBP affected EN-MSC differentiation through loss of the EN-MSC phenotype (Fig. 1C) .
cDNA microarray and signaling pathways. Next, we investigated how phthalate affected EN-MSC differentiation using whole-genome cDNA microarrays to examine BBP regulation of gene expression. For these experiments, we added 1 μM BBP to a culture of EN-MSCs for 24 h prior to the isolation of total RNA and subsequent cDNA synthesis. We focused the down-regulated gene after BBP-treatment in MSCs. Table 1 lists the top 15 genes that were down-regulated after BBP treatment, which underscores the remarkable potential of this compound to alter EN-MSC differentiation. Analysis of cDNA microarray data revealed how individual genes interacted and coordinated to affect regulation of biological functions and signaling pathways. The top biofunctions associated with the gene expression profiles of BBP-treated MSCs were identified using Ingenuity Pathway Analysis and are listed in Supplementary Table S1 : diseases and disorders, molecular and cellular functions, and physiological system development and function.
Finally, we identified the major biofunction categories associated with cellular differentiation. Table 2 lists the genes associated with skeletal and muscular disorders, cell morphology, and tissue development. Biofunctions of the candidate genes responsible for BBP-induced alterations of EN-MSC differentiation were determined.
Gene expression in BBP-treated MSCs. The gene was found to have overlapping contributions among the BBP deregulated genes whose functions were associated with skeletal and muscular disorders, cell morphology, and tissue development and were excluded which are irrelevant to MSCs from intersection of all three categories. We found the three genes, namely, PITX2 (fold change = 0.596, P = 0.00007), SRC (fold change = 0.532, P = 0.000082), and TLR2 (fold change = 0.645, P = 0.00078) ( Fig. 2A) . First, we examined gene expression levels of these three genes in EN-MSCs after 1 μM BBP treatment for 24 h. The data revealed that expression of the three genes decreased in BBP-treated MSCs (Fig. 2B ). These data suggested that PITX2, SRC, and TLR2 play a vital role in mediating the effects of BBP on EN-MSC differentiation. In previous studies, PITX2, a homeodomain transcription factor, is essential for normal development and differentiated of tissue 20, 21 . Recent studies have reported that SRC plays a role in signal pathways involved in cell proliferation, growth, survival osteoclast and intestinal epithelial cell differentiation 22, 23 . In addition, TLR2 play a central role in the innate immune system and is associated with B cell differentiation 24 . We then investigated whether miRNAs that target SRC, PITX2, and/or TLR2 mRNAs mediate the effects of BBP on EN-MSC differentiation. We targeted PITX2, which has been reported to be associated with myogenesis [25] [26] [27] [28] . We attempted to identify miRNAs that serve as upstream regulators of EN-MSC differentiation, i.e., miRNAs that might be affected by BBP; specifically that were affected by BBP in EN-MSC differentiation, and specifically we used the prediction software miRanda (http://www.microrna.org/) to select three candidate miRNA regulators of PITX2: miR-137, miR-141 and miR-200a. BBP treatment increased the level of miR-137 in EN-MSCs, whereas the levels of miR-141 and miR-200a were not affected (Fig. 2C) . Next, we examined whether PITX2 expression was affected by miR-137. Overexpression of precursor-miR-137 in EN-MSCs reduced the PITX2 transcript level (Fig. 2D ). These data suggested that the BBP-induced effects on the level of PITX2 transcript are mediated through miR-137.
miR-137 down-regulates PITX2 by targeting the 3′UTR.
To test whether miR-137 targets PITX2, the 3′UTR of PITX2, which contains a miR-137 binding site, was cloned into the pGL-2 control vector to create a luciferase reporter system (Fig. 3A) . Co-transfection was performed with pre-miR-137 (precursor control) and pGL2-PITX2 3′UTR (mutant version of pGL2-PITX2 3′UTR). Cotransfection was performed with pre-miR-137 (precursor control) and either wild-type pGL2-PITX2 3′UTR or a mutant derivative. The luciferase reporter showed that miR-137 inhibited the PITX2 wild-type reporter but did not affect the PITX2 mutant reporter (Fig. 3B) .
Further, we performed western blotting to confirm whether miR-137 affects the protein level of PITX2 and MyoD. Over-expression of miR-137 decreased the level of PITX2 and MyoD, whereas knock-down of mir-137 increase the levels of PITX2 and MyoD (Fig. 3C ). These results indicated that, in our experimental system, PITX2 was indeed a direct target of miR-137.
Taken together, these results showed that BBP reduced PITX2 expression in EN-MSC differentiation ( Fig. 2B ) via increased expression of miR-137 (Fig. 2C ), its upstream negative regulator. Therefore, we investigated whether myogenesis was affected by miR-137 in EN-MSCs. Ectopic miR-137 expression decreased the expression of the myogenic marker MyoD, PITX2 in differentiated condition (Fig. 3D) , which supports the hypothesis that BBP exerts its effect on EN-MSC myogenic differentiation through the action of miR-137. miR-137 affects myogenesis through PITX2. To understand the extent to which miR-137 affects EN-MSC differentiation through PITX2 directly, we used a short hairpin RNA (shRNA) to knockdown PITX2 expression (Fig. 4A) . When EN-MSC was transfected with PITX2-shRNA-1 or PITX2-shRNA-2, PITX2 and MyoD expression were down-regulated ( Fig. 4B and E ). PITX2 overexpression (Fig. 4C ) in the cells increased PITX2 and MyoD expression ( Fig. 4D and E) . These data confirmed that PITX2 expression level had a significant effect on EN-MSC myogenic differentiation.
Discussion
Phthalates are omnipresent toxins in the environment, and they have been classified as EDCs that can interfere with elimination of natural hormones that are responsible for homeostasis and essential for growth and development 29 . In previously study, Upson K et al. finding that urinary concentration of the BBP metabolite MBzP (mono-n-benzyl phthalate) may be associated with increased risk of endometriosis 14 . Reddy et al. has demonstrated the relationship between exposure to polyethylenes such as BBP and the occurrence of endometriosis in infertile women 15 . These speculate the correlation between the exposures of BBP and endometrial diseases. In addition, the effects of exposure to BBP and its main metabolite MnBP (mono-n-butyl phthalate) and MBzP may have same effect in animal model 30, 31 . The pattern of malformations produced by MnBP was similar to that produced by BBP 31 . Previous study also reported that BBP, MnBP and MBzP caused embryolethality and malformations in mice 30 .
MSCs play an important role in tissue homeostasis, serving as a source of renewable progenitor cells to replace or repair tissue cells throughout adult life 32, 33 . In the present study, we found that BBP decreased EN-MSC differentiation. We identified one such target gene PITX2, which is a homeobox transcriptional factor that regulates muscle development 21, 34 . Normally, PITX2 and MyoD transcription levels increase during myogenic differentiation 21 ; thus, the observed reduction in PITX2 and MyoD transcripts offers further evidence that BBP alters transcriptional regulation during stem cell differentiation in endometrial tissues. In addition, PITX2 is essential for development of multiple organs, including the lung, heart and pituitary gland 35 . Therefore, environmental hormones might affect tissue development through PITX2.
In the present study, we used microarray analysis to identify genes whose expression levels were altered by BBP. Our results found that TLR2 and SRC were dysregulated in response to BBP treatment. This finding is consistent with previous studies, we found TLR2 gene related to immune 24 , and SRC which has been described to be related with epithelial cell differentiation 23 . A previous study has investigated the alteration in the gene expression following phthalate treatment in which exposure to this compound caused a dys-regulation in the expression of many genes, including apoptosis-, cell proliferation-, and immune response-related genes 36, 37 . TLR2 plays a key role in immune system and is found in immune cell, such macrophages, B cell and mast cells 24 . MSC display unique suppressive properties on T-cell immunity, since TLR expressed on human MSC enhanced the immunosuppressive phenotype of MSC 38, 39 . Immunosuppressive properties of MSC most probably depend on environmental factors 40 . Interestingly, functional role of phthalate-elicited differential gene expression is associated with immune system. It may be informative to investigate the potential mechanism related to BBP effects on immune system.
In the present study, we investigated how phthalate affected EN-MSC differentiation using whole-genome cDNA microarrays to examine BBP regulation of gene expression. Although the top 15 down-regulated genes were not found to have overlapping contributions among the BBP deregulated genes whose functions were associated with skeletal and muscular disorders, cell morphology, and tissue development. However, some studies have reported that these genes, TDGF1 41 , ALX1 42 , LGI3 43 , ADH4 44 , VSX1 45 , ZIC3 46, 47 , are relevant to stem cell differentiation or tissue development. As expected, phthalate exposure might affect cell differentiation or development.
Recently, several studies showed that exposure to various environmental or growth factors regulates the expression of certain specific miRNAs 48, 49 . Although several studies have demonstrated that miR-137 functions in neurogenesis or adipogenesis in stem cells 50, 51 , ours is the first study to demonstrate that BBP administration modulates miR-137 level and to identify PITX2 as a novel miR-137 downstream target during myogenic differentiation.
In conclusion, we characterized the roles of miR-137 in myogenic hMSC differentiation and elucidated the mechanisms of BBP action in this process. These findings contribute to our understanding of hMSC differentiation and underscore the hazardous potential of environmental hormones.
Methods
Cell line. EN-MSCs were isolated and collected from 3 different endometrium biopsies after hysterectomy for non-endometrial benign pathological condition, such as uterine prolapse. These women had not taken exogenous hormones for three months prior to surgery. This study was approved by the Institutional Review Board of Kaohsiung Medical University, and informed consent was obtained from each patient (KMUH-IRB-20140031). All experiments were performed in accordance with relevant guidelines and regulations. Written informed consent was obtained from each participant. EN-MSCs were isolated and purified as described 5 . Briefly, endometrial tissue was minced with sterile scissors and subjected to enzymatic digestion with 1 mg/ml type II collagenase for 60 to 90 minutes. After digestion, these digested tissues were filtered by wire sieves with serial different pores (100 μm, 70 μm and 40 μm diameter pores) to remove epithelial cells. These endometrial stromal cells were collected. For EN-MSC isolation, endometrial stromal cells (passage 5) were seeded in triplicate at clonal density; 200 cells per 100 mm Petri dish. After incubation of 21 days, large colonies were isolated and separated into single suspended cells by trypsinization. These cells were diluted and seeded in a 96-well plate, density at one cell per well. After incubation of 14 days, proliferated cells (which were from one single cell) were trypsinized and cultured in a 100 mm Petri dish. These early-passage EN-MSCs were used in the following experiments. EN-MSCs were characterized using MSC phenotypes and differentiation induction (i.e., adipogenesis, osteogenesis, and chondrogenesis,) and by gene expression, i.e., POU5F1 (previously known as OCT-4), CD29, CD44, CD49f, CD90, CD105, CD146, CD140b, and SUSD2 by flow cytometry 5 (Supplementary Material). EN-MSCs were cultured in modified MCDB 153 medium (Keratinocyte-SFM, Gibco-Life Technologies, Carlsbad, CA) and Dulbecco's Modified Eagle's Medium: Nutrient Mixture F12 (Gibco-Life Technologies) (1:2, v/v) supplemented with 10% fetal bovine serum (Gibco-Life Technologies), 2 mM N-acetyl-l-cysteine (A8199, Sigma-Aldrich, St. Louis, MO) and 0.2 mM l-ascorbic acid 2-phosphate (Asc 2P; A8960, Sigma-Aldrich), and incubated at 37 °C in a humidified atmosphere with 5% CO 2 .
Differentiation experiments. EN-MSCs were seeded at 5 × 10 4 cells per well in a 6-well plate; differentiation conditions were applied the following day. Adipogenic differentiation of EN-MSCs was induced by treatment with 500 μM of 3-isobutyl-1-methylxanthine (I7018, Sigma-Aldrich), 1 μM dexamethasone (D8893, Sigma-Aldrich), 1 μM indomethacin (I8280, Sigma-Aldrich), and 10 μg/mL insulin (I1882, Sigma-Aldrich) (IDI-I medium) for 2 d, and followed by insulin treatment for 1 d. After 4 cycles of treatment over 12 d, the cells were fixed with 4% paraformaldehyde and stained with 0.2% Oil Red O for 30 min (O0625, Sigma-Aldrich) 52 . For osteogenic differentiation, 10 nM dexamethasone (D8893, Sigma-Aldrich), 50 μM Asc-2P, and 10 mM β-glycerophosphate disodium (G9891, Sigma-Aldrich), also commonly known as DAG medium, were added to the growth medium for 2 weeks. Medium changes and treatments were renewed once every 3 d 52 . At 14 d after the initiation of differentiation, the cells were stained with 2% Alizarin Red S (A5533, Sigma-Aldrich) to assay for osteocytes 53 . For myogenic differentiation, 5 μM 5-azacytidine (A2385, Sigma-Aldrich) was added to the growth medium for 24 h, after which the myogenic induction medium was replaced with normal growth medium 54 . The medium was changed every 3 d for the remainder of the culture. On day 14 after induction of myogenic differentiation, cells were fixed in 4% paraformaldehyde, stained for MyoD (ab64159, Abcam), and then examined for the presence of myocytes by immunofluorescence. After reaching 90% confluence, the cells were harvested and reseed in 15 ml tube at 2.5 × 10 5 cells/tube. Chondrogenic differentiation of EN-MSCs was induced by treatment with 10 ng/mL TGF-β1 (T1654, Sigma-Aldrich), 50 μM Asc-2P, and 6.25 μg/mL insulin (TAI medium) in the 24 well plates. Medium was changed every 3 d 52, 55, 56 . After 14 d, the micromass was fixed in 4% paraformaldehyde and then examined for chondrocytes by staining with, 1% Alcian Blue 8-Gx, pH 1.0 (A5268, Sigma-Aldrich).
Chemicals and Reagents. BBP (98%) was purchased from Sigma-Aldrich and diluted with ethanol to a concentration 1000-fold higher than the final concentration that was used in cell culture.
quantitative real-time PCR analysis. qPCR was used to assess gene and miRNA expression. RNAs were extracted from EN-MSCs using TRI Reagent (Sigma-Aldrich). Reverse transcription was carried out with 1.5 μg of RNA using the Deoxy + HiSpec RT kit (Yeastern, Taipei, Taiwan) and TaqMan MicroRNA Reverse Transcription kit (Applied Biosystems, Foster City, CA). The expression of various transcripts and mature miRNAs was assessed by real-time PCR with Power SYBR Green PCR Master Mix (Applied Biosystems) and TaqMan MicroRNA Assay using an ABI 7900 Real-Time PCR system (Applied Biosystems). The primer sets used in this study are listed in Supplemental Table S4 . Changes in gene expression were calculated relative to 18S RNA using the 2 −ΔΔCt method. MiRNAs expression were normalized to endogenous small nuclear U6B RNA using the 2 −ΔΔCt method.
Immunofluorescence. After treatment, EN-MSCs were rinsed several times with PBS and fixed in 4% paraformaldehyde for 5 min, permeabilized with 0.5% Triton X-100 in PBS for 5 min. The fixed cells were probed with Rabbit-MyoD antibody (1:1000, ab64159, Abcam) and secondary antibody followed by Alexa Fluor 568-conjugated goat anti-rabbit IgG (1:500, A11011, Gibco-Life Technologies) for 45 min. Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI, 1 μg/ml, Roche). Images were obtained using a fluorescence microscope (Nikon Eclipse TE 300, Tokyo, Japan).
cDNA microarray and data analysis. RNA was extracted from EN-MSCs using TRI Reagent. RNA integrity number >7.0 were used to synthesize the first strand cDNA via reverse transcription using an Illumina Total Pre RNA Amplification Kit (Ambion, Austin, TX, USA). Amplified cRNA samples were hybridized with streptavidin-Cy3 and scanned on the Illumina Beadstation GX. To determine differentially expressed genes, microarray data (n = 2 in each group) were analyzed using the gene expression module in Illumina Beadstudio software, version 3.3.7. Intensity data were normalized using the Beadstudio cubic spline algorithm and calculated with Beadstudio software according to the manufacturer's protocols. The gene expression fold change of the stimulated cells was calculated as the average signal value relative to the average signal value for the control cells. Genes were selected based on a p-value cut-off (after adjustment) of p < 0.05 to control the false discovery rate (FDR) 57, 58 . A significant down-regulation was defined as a foldchange ≥1.5. We applied the Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, California) tool for analysis of canonical pathways and participating networks using the cDNA microarray data.
Ingenuity Pathway Analysis. The molecular functions of the unique gene analysis of the BBP-induced genes were performed using Ingenuity Pathway Analysis (IPA) software (IPA, Ingenuity Systems, Redwood City, California). Genes from the data set that met the cutoff of and were associated with biological functions and/or diseases in the Ingenuity Pathways Knowledge Base were included in the analysis. Western Blot. The proteins were extracted with RIPA lysis buffer (Millipore, Billerica, MA, USA) containing several protease and phosphatase inhibitors (GBiosciences, St Louis, MO, USA). The protein content was determined by a Bio-Rad Protein Assay system (Bio-Rad, Hercules, CA, USA). Equal amounts of protein were separated by 10% SDS-PAGE and transferred to PVDF membranes (Millipore, Bedford, MA, USA). Then the membrane was incubated with primary antibodies: anti-MyoD (ab126726, 1:1000, abcam), anti-PITX2 (ab55599, 1:1000, abcam), and anti-actin (1:5000; Sigma-Aldrich). The secondary antibodies used were goat-anti-mouse or anti-rabbit IgG conjugated to HRP (Santa Cruz Biotechnology), and the ECL reagents (Millipore) were used for immunodetection Statistical Analysis. Statistical analyses were performed using One-way ANOVA followed by Tukey's HSD test for comparing differences between multiple groups and Student's t-test for comparing differences between two groups. Data represented the mean ± standard deviation. P values < 0.05 were considered statistically significant.
